Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.39 | -23.41 |
PEG Ratio (TTM) | 0.00 | 15.22 |
P/S Ratio (TTM) | N/A | 50.19 |
P/B Ratio (TTM) | 0.67 | 18.75 |
P/FCF Ratio (TTM) | -0.47 | -3.82 |
Price to 5YR AVG Earnings Ratio | -0.35 | -3.63 |
Price to 5YR AVG FCF Ratio | -0.68 | -9.39 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -134.50% | -5.51% |
ROE (TTM) | -151.10% | 15.68% |
Net Profit Margin (TTM) | N/A | -2,035.83% |
ROIC 5YR AVG | -260.96% | 14.56% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -192.10% | -488.71% | -348.89% |
Revenue | N/A | N/A | N/A |
Net Income | -4.75% | -99.24% | -119.59% |
Cash Flow | -16.42% | -55.27% | -31.99% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.82 | 6.23 |
Quick Ratio (TTM) | 4.82 | 5.95 |
D/E Ratio (TTM) | 0.02 | -15.66 |
Interest Coverage (TTM) | -3.18 | -1.78 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 14.20 |
LTL to 5YR AVG FCF | -0.01 | 0.17 |
Shares Outstanding Growth 5YR AVG | 522.11% | 125.48% |